A Slice of Europe: MD Anderson looks to invest in EU Immuno-Oncology
MD Anderson is expanding its Immatics sharehold to spawn new Houston-based subsidiary Immatics US through…
MD Anderson is expanding its Immatics sharehold to spawn new Houston-based subsidiary Immatics US through…
So preliminary trial results look good - it could be that the next phase will go…
Taking care of diabetes is still far too complex currently. In future, Sanofi and Google…
What happens when your liver stops working? The toxins your body continuously produces will no longer…
PlugMed has been awarded €2 million of funding, as part of the World Innovation Challenge…
Orthobiology is a field of biomedical technology, which develops new devices and products for skeletal…
Little could the young Joel Gibbard have ever imagined that those Meccano games he once…
The revolutionary Equilia system, meant to treat heart failure, has been successfully implanted for the…
Imagine you could use a glue to fix a hole or week zone inside your…
Six months after the surgery, the first Spanish with a bionic eye has gone from…
Last September 24th was held the Baden-Württemberg Healthcare Industry Forum 2014, organized by BIOPRO the biotech…
The first intelligent artificial heart has been twice implanted in France within clinical trials. It has…